Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer

This study has suspended participant recruitment.
Sponsor:
Information provided by:
Hokkaido Gastrointestinal Cancer Study Group
ClinicalTrials.gov Identifier:
NCT00209664
First received: September 13, 2005
Last updated: January 31, 2006
Last verified: January 2004
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: December 2008
  Estimated Primary Completion Date: No date given